This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Relationship: 3521
Title
Decreased, Progesterone levels leads to Reduction, androstenedione
Upstream event
Downstream event
Key Event Relationship Overview
AOPs Referencing Relationship
Taxonomic Applicability
Term | Scientific Term | Evidence | Link |
---|---|---|---|
mammals | mammals | High | NCBI |
Sex Applicability
Sex | Evidence |
---|---|
Mixed | High |
Life Stage Applicability
Term | Evidence |
---|---|
All life stages | High |
Key Event Relationship Description
This key event relationship links a decrease in progesterone to a reduction in androstenedione.
CYP17A1 is responsible for the conversion of progesterone to 17-OH-progesterone which can then be converted into the weak androgen androstenedione by the same enzyme. Progesterone can be converted to 17-OH-progesterone by CYP17A1 or converted by CYP21 to form corticosterone. When CYP17A1 is dominant over CYP21, which depends on tissue specific gene expression, synthesis of 17OH-progesterone takes place. (Bhatt et al., 2017; V et al., 2018; WL, 2017). Therefore, since progesterone is one of the possible precursors of androstenedione, if levels of progesterone decrease, then androstenedione levels may decrease as well.
Evidence Collection Strategy
The KER describes a generally recognized and understood process, i.e. canonical knowledge. The aim of the literature search was therefore to identify review articles and book chapters that summarise the canonical knowledge. PubMed was searched using key words related to steroidogenesis. The search was restricted to reviews from the last 10 years.
Evidence Supporting this KER
Biological Plausibility
It is well established that the synthesis and presence of progesterone plays a role for levels of androstenedione.
The pathway in which progesterone is converted to androstenedione is known as the Δ4 pathway. This pathway is present and active in mice, rats, and guinea pigs but minor in humans (Bhatt et al., 2017). Androstenedione can also be formed through the Δ5 pathway, which converts pregnenolone, into its hydroxylated form, and ultimately into DHEA and androstenedione. This pathway is dominant in humans and primates (Flück et al., 2003; Miller & Auchus, 2011). Furthermore, the Δ4 pathway was recently observed in human fetal Leydig cells during GW8-9 to produce mainly progesterone but also androgens in the testis. This is temporary as they switch to Δ5 pathway after this to produce higher levels of androgens as Leydig cells mature (Bhatt et al., 2017; Savchuk et al., 2019).
Empirical Evidence
Uncertainties and Inconsistencies
Progesterone is a precursor to other steroid hormones as well, like corticoids (T et al., 2015; Taraborrelli, 2015). The levels of the hormones can also depend on the enzyme activity of CYP17A1 (FK & RJ, 2015; M et al., 2017; Sherbet et al., 2003). Therefore, the reduction of progesterone levels doesn’t always translate to an effect on androstenedione levels.
Known modulating factors
Quantitative Understanding of the Linkage
Response-response Relationship
Time-scale
Known Feedforward/Feedback loops influencing this KER
Androstenedione itself can increase progesterone synthesis (Goyeneche et al., 2002; López-García et al., 2008)
Domain of Applicability
Taxonomic applicability
This KER can be applicable to vertebrates as these processes are well conserved, but we have decided to focus on mammals (Bremer & Miller, 2014; Flück et al., 2003; Taraborrelli, 2015).
Life stage applicability
It is also applicable during development and adulthood (Bremer & Miller, 2014; Taraborrelli, 2015).
Sex applicability
This KER is applicable in both sexes as it is observed in Leydig cells and in ovaries (Bremer & Miller, 2014; Miller & Auchus, 2011; Taraborrelli, 2015).
References
Bhatt, M. R., Khatri, Y., Rodgers, R. J., & Martin, L. L. (2017). Role of cytochrome b5 in the modulation of the enzymatic activities of cytochrome P450 17α-hydroxylase/17,20-lyase (P450 17A1). The Journal of Steroid Biochemistry and Molecular Biology, 170, 2–18. https://doi.org/10.1016/j.jsbmb.2016.02.033..
Bremer, A. A., & Miller, W. L. (2014). Regulation of Steroidogenesis. In Cellular Endocrinology in Health and Disease (pp. 207–227). Elsevier. https://doi.org/10.1016/B978-0-12-408134-5.00013-5
FK, Y., & RJ, A. (2015). The diverse chemistry of cytochrome P450 17A1 (P450c17, CYP17A1). The Journal of Steroid Biochemistry and Molecular Biology, 151, 52–65. https://doi.org/10.1016/j.jsbmb.2014.11.026
Flück, C. E., Miller, W. L., & Auchus, R. J. (2003). The 17, 20-Lyase Activity of Cytochrome P450c17 from Human Fetal Testis Favors the Δ 5 Steroidogenic Pathway. The Journal of Clinical Endocrinology & Metabolism, 88(8), 3762–3766. https://doi.org/10.1210/jc.2003-030143
Goyeneche, A. A., Calvo, V., Gibori, G., & Telleria, C. M. (2002). Androstenedione Interferes in Luteal Regression by Inhibiting Apoptosis and Stimulating Progesterone Production1. Biology of Reproduction, 66(5), 1540–1547. https://doi.org/10.1095/biolreprod66.5.1540
López-García, C., López-Contreras, A. J., Cremades, A., Castells, M. T., Marín, F., Schreiber, F., & Peñafiel, R. (2008). Molecular and Morphological Changes in Placenta and Embryo Development Associated with the Inhibition of Polyamine Synthesis during Midpregnancy in Mice. Endocrinology, 149(10), 5012–5023. https://doi.org/10.1210/en.2008-0084
M, K. S., J, J., Z, T., P, K., L, L., & J, H. (2017). The role of CYP17A1 in prostate cancer development: structure, function, mechanism of action, genetic variations and its inhibition. General Physiology and Biophysics, 36(5), 487–499. https://doi.org/10.4149/gpb_2017024
Miller, W. L., & Auchus, R. J. (2011). The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders. Endocrine Reviews, 32(1), 81–151. https://doi.org/10.1210/er.2010-0013
Savchuk, I., Morvan, M. L., Antignac, J. P., Kurek, M., Le Bizec, B., Söder, O., & Svechnikov, K. (2019). Ontogenesis of human fetal testicular steroidogenesis at early gestational age. Steroids, 141, 96–103. https://doi.org/10.1016/j.steroids.2018.12.001
Sherbet, D. P., Tiosano, D., Kwist, K. M., Hochberg, Z., & Auchus, R. J. (2003). CYP17 Mutation E305G Causes Isolated 17,20-Lyase Deficiency by Selectively Altering Substrate Binding. Journal of Biological Chemistry, 278(49), 48563–48569. https://doi.org/10.1074/jbc.M307586200
T, M., S, I., S, K., A, U., & K, M. (2015). Transcriptional regulation of genes related to progesterone production. Endocrine Journal, 62(9), 757–763. https://doi.org/10.1507/endocrj.EJ15-0260
Taraborrelli, S. (2015). Physiology, production and action of progesterone. Acta Obstetricia et Gynecologica Scandinavica, 94, 8–16. https://doi.org/10.1111/aogs.12771
V, S., DM, S., & BJ, C. (2018). Current knowledge on the acute regulation of steroidogenesis. Biology of Reproduction, 99(1), 13–26. https://doi.org/10.1093/biolre/ioy102
WL, M. (2017). Steroidogenesis: Unanswered Questions. Trends in Endocrinology and Metabolism: TEM, 28(11), 771–793. https://doi.org/10.1016/j.tem.2017.09.002